New Passive Funds tracking Nifty Indices launched in Japan and Korea
7 new Passive Funds launched in 2023 MUMBAI, India--(BUSINESS WIRE)--#AUM--In the calendar year 2023, seven…
3 years ago
CSL and Arcturus Therapeutics’ ARCT-154 Demonstrates Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster
Study conducted by Meiji Seika Pharma in Japan Data follow approval of the world’s first…
3 years ago
JCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of Gene Therapy Collaboration
HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCRâ€) announced…
3 years ago
SCG International opens a new office in Saudi, expanding its ‘global connector’ role with resilient supply chain solutions, eyeing new opportunities in the Construction sector driven by Giga-projects
RIYADH, SAUDI ARABIA - Media OutReach Newswire - 21 December 2023 - SCG International is…
3 years ago
FBS and Education Africa Bring Christmas Cheer to Families in Need in South Africa
GAUTENG, SOUTH AFRICA - Media OutReach Newswire - 21 December 2023 - FBS, a leading…
3 years ago
JCR Announces Research Collaboration, Option and License Agreement with Alexion on Discovery of Oligonucleotide Therapeutics Using J-Brain Cargo® Technology
New collaboration aims to create innovative oligonucleotide therapeutics that enable target delivery to certain tissues…
3 years ago
Rampur Indian Single Malt Whisky Becomes the Only Whisky Brand From India on the List of ‘Top 100 Premium Wine and Spirits Brands of the World 2023’
Another product from the house of Radico Khaitan on the list is Jaisalmer Indian Craft…
3 years ago
Alcoa appoints Matt Reed as EVP and Chief Operations Officer
PITTSBURGH--(BUSINESS WIRE)--Alcoa Corporation (NYSE: AA) today announced that it has appointed Matt Reed as Alcoa’s…
3 years ago
BeiGene to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--$BGNE #BeiGene--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE:…
3 years ago
Almirall Initiates First Phase I Clinical Study of ALM223, an Interleukin 2 Mutant Fusion Protein for Autoimmune Diseases
The phase I study will evaluate the safety, pharmacokinetics, immunogenicity, and pharmacodynamics of ALM223 ALM223…
3 years ago